Angion Biomedica Corp. (ANGN) has a consensus analyst rating of Hold, based on 4 analysts covering the stock. Of those, 1 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for ANGN is $1.50, representing a +50.0% upside from the current price of $1. Price targets range from a low of $1.50 to a high of $1.50.
